Trichomoniasis
exp date isn't null, but text field is
Trichomoniasis is one of the most common STIs, caused by a parasitic protozoan Trichomonas vaginalis. Women are mostly symptomatic while men are asymptomatic carriers.
Causes
- T. vaginalis
Symptoms In women - Vulvo-vaginal itching, burning or soreness - Pain during sex (major complaint) - Post-coital bleeding, lower abdominal pain
In men - Urethritis, urethral pruritus, dysuria, testicular pain, lower abdominal pain |
Signs In women - Purulent, bloody or frothy-yellow-green discharge - Vulval inflammation - Pelvic inflammatory disease
In men Urethral discharge |
Differential diagnosis
- Gonorrhoea
- Trichomoniasis
- May cause cervicitis or vaginitis
Complications
- Acute salpingitis
- Adverse pregnancy outcomes, particularly premature rupture of membranes, pre-term delivery and low birth weight
Investigations
- Microscopy (this is the gold standard for diagnosis)
- Histology
Treatment objectives
- Eliminate the causative organism in the patient and sexual partner(s)
- Prevent re-infection
- Consistent and correct use of condoms(Male and Female condoms)
- Manage symptoms
- Prevent transmission of the infection
- Prevent complications
Non-pharmacological treatment
- Advice on avoidance of alcohol consumption during treatment
- Advise patient on personal hygiene
Pharmacological treatment
Adult: Metronidazole oral 2 g as a single dose OR 400 mg or 500 mg every 12 hours for 7 days OR Tinidazole oral 2 g orally in a single dose OR 500 mg orally every 12 hours for 5 days Note: Patients should not consume alcohol during the course of treatment or during the 24 hours after the completion of the medication. Pregnancy Metronidazole 2g in a single doseNote: Metronidazole is not recommended for pregnant women in the first trimester Lactation In lactating women, breastfeeding must be withheld during treatment and until 12-24 hours after the last dose to reduce exposure to the infant. Note: Patients on tinidazole therapy should not consume alcohol during therapy or for 72 hours after completion of medication. Neonatal infections Metronidazole oral 5 mg/kg 3 times daily for 5 days |
Prevention
- Advise patient and partner(s) to abstain from sex while on treatment
- Re-screen at 3 months post-therapy for sexually active women, as they have a high risk of re-infection
- Limit number of sexual partners
- Advice on the correct and consistent use of male or female condoms
Referral
- Patients with conditions not responding to the above treatment should be referred for specialized management.